Targeting BCMA in multiple myeloma: Insights from COMy and EHA 2024

touchPODCAST

touchCONGRESS for touchONCOLOGY

Listen to multiple myeloma expert Prof. María-Victoria Mateos review key data for BCMA-targeting agents in the treatment of multiple myeloma presented at the international Controversies in Multiple Myeloma (COMy) and European Hematology Association (EHA) 2024 congresses. Prof. Mateos is then joined by fellow experts Dr Rakesh Popat and Prof. Evangelos Terpos to discuss how these data may apply in clinical practice.

Overview

• Data reviews with Prof. Mateos,
• Expert panel discussions with Prof. Mateos, Dr Popat and Prof. Terpos on the themes below

Clinical themes

1. Approved indications for BCMA-targeting agents,
2. New approaches to the use of existing BCMA-targeting agents,
3. Emerging BCMA-targeting agents

The internationally renowned multiple myeloma expert faculty

• Prof. María-Victoria Mateos: Salamanca, Spain,
• Dr Rakesh Popat: London, UK,
• Prof. Evangelos Terpos: Athens, Greece

This touchPODCAST is for HCPs outside of the USA and UK only.

This activity is funded by an independent medical education grant from GSK. This activity is provided by touchIME. touchIME is an EBAC® accredited provider.

For further information visit our website: https://touchoncologyime.org/bcma-mm-comy-eha-2024